cryptotanshinone has been researched along with Alveolitis, Fibrosing in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, P; Lu, J; Pan, X; Quan, G; Wan, W; Wang, X; Wu, Z; Zhang, Y | 1 |
| Gan, C; Li, Y; Liu, H; Tan, Z; Wang, L; Xie, Y; Yao, Y; Ye, T; Yin, W; You, J; Zhang, Q | 1 |
| Chen, J; Chen, S; Liu, P; Lu, J; Lu, W; Wang, Q; Xu, S; Zhang, X; Zhang, Y; Zhong, Z; Zhou, T | 1 |
3 other study(ies) available for cryptotanshinone and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Inhalable cryptotanshinone spray-dried swellable microparticles for pulmonary fibrosis therapy by regulating TGF-β1/Smad3, STAT3 and SIRT3 pathways.
Topics: Administration, Inhalation; Animals; Bleomycin; Phenanthrenes; Pulmonary Fibrosis; Rats; Signal Transduction; Sirtuin 3; Sirtuins; Smad3 Protein; STAT3 Transcription Factor; Transforming Growth Factor beta1 | 2022 |
Cryptotanshinone reverses the epithelial-mesenchymal transformation process and attenuates bleomycin-induced pulmonary fibrosis.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Disease Models, Animal; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Humans; Male; Mice; Mice, Inbred C57BL; Phenanthrenes; Pulmonary Fibrosis; Rats | 2020 |
Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways.
Topics: Animals; Bleomycin; Cell Line; Fibroblasts; Humans; Lung; Male; Phenanthrenes; Protective Agents; Pulmonary Fibrosis; Rats, Sprague-Dawley; Respiratory Function Tests; Signal Transduction; Smad Proteins; STAT3 Transcription Factor | 2019 |